| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,375.0 | 1,281.0 |
| Profit before tax | 58.0 | -3.0 |
| Net income | 32.0 | -28.0 |
| EPS (diluted, $ a share) | $0.09 | $-0.08 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +7.3% |
|---|---|
| Operating margin | 11.3% |
10-Q filed with the SEC, NYSE: BLCO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Bausch & Lomb Corp: key numbers
- Share price
- $20.88Close, Nov 16
- Market cap
- $7.46B
- Shares outstanding
- 357.5MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Ophthalmic GoodsSIC 3851
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Bausch & Lomb Corp
All →Bausch & Lomb SVP, Controller and CAO Frederick Munsch Sells $2.29M of Stock
Frederick Munsch, SVP, Controller and CAO, sold 112,015 shares of Bausch & Lomb Corp at $20.48 a share, worth $2.29M in total on Oct 29, 2026. Shares held after the trade: 45,831 (-71.0%).
- Value
- $2.29M
- Shares
- 112,015
- Price
- $20.48
- Role
- SVP, Controller and CAO
- Holding change
- -71.0%
- Trade date
- Oct 29, 2026
Bausch & Lomb Leadership Change
Nathalie Bernier has resigned from the Board of Directors and the Science and Technology Committee of Bausch + Lomb Corporation, effective October 28, 2026. In connection with her departure, the company agreed to pay prorated cash compensation and accelerate the vesting of her 2026 restricted share unit awards. The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.
Bausch & Lomb Financial Results
Bausch + Lomb reported third-quarter 2026 revenue of $1.375 billion, representing 7% reported growth and 8% constant currency growth year-over-year. The company achieved GAAP net income of $32 million and raised its full-year 2026 guidance for both revenue and Adjusted EBITDA.
- Term
- Q3 2026
“Our third-quarter performance reflects the strength and breadth of the business, with growth across all three segments and continued expansion in profitability.”
Thomas J. Appio, chairman and interim CEO
“We have delivered against the commitments outlined at Investor Day for four consecutive quarters, and I believe there are additional opportunities to improve execution, enhance profitability and create even more value over time.”
Thomas J. Appio, chairman and interim CEO
Bausch & Lomb Leadership Change
Bausch + Lomb announced that CEO Brent Saunders has mutually agreed with the Board to depart the company and the Board effective October 12, 2026. Thomas J. Appio, the current Chairman of the Board and CEO of parent company Bausch Health, has been appointed interim CEO. In connection with his departure, Mr. Saunders will receive a $75.5 million lump-sum cash payment and forfeit all outstanding equity awards.